Investors frown on Fibrocell Science's public offering

|About: Fibrocell Science, Inc. (FCSC)|By:, SA News Editor

Fibrocell Science (FCSC) slips after announcing a public offering with a 15% underwriter option.

Proceeds will go towards trials for new azficel-T indications — the cell-based product is currently approved for "smile lines". (PR)

Shares -14% premarket.